Zdrowie i gospodarka · 25/05/2023

FDA Announces Draft Guidance on Generally Accepted Scientific Knowledge for Drug and Biological Products

The Food and Drug Administration (FDA) is releasing a draft guidance to help pharmaceutical companies determine if they can use generally accepted scientific knowledge to meet regulatory requirements for new drug applications or biologics licensing applications.